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Abstract Surgically correctable congenital anomalies cause a substantial burden of global morbidity and mortality.
These anomalies disproportionately affect children in low- and middle-income countries (LMICs) due to sociocul-
tural, economic, and structural factors that limit the accessibility and quality of pediatric surgery. While data from
LMICs are sparse, available evidence suggests that the true human and financial cost of congenital anomalies is
grossly underestimated and that pediatric surgery is a cost-effective intervention with the potential to avert significant
premature mortality and lifelong disability.
Introduction
If surgery is the ‘‘neglected stepchild of global health’’ [1],
pediatric surgery is the child not yet born. Despite powerful
strides forward in the treatment of congenital anomalies, or
birth defects, the benefits of these diagnostic and thera-
peutic advances have been largely confined to high-income
countries (HICs), where many once fatal conditions can
now be treated, with mortality rates under 10 %. In con-
trast, mortality rates from hospital-based data in low- and
middle-income countries (LMICs) for common anomalies
often rise to 20–85 % [2–17]. Patients with immediately
life-threatening conditions may die in transit or at home,
and never be entered into such hospital-based measures
[18, 19]; the resultant hidden mortality represents an oft-
underestimated addition to the burden of disease. This
review article will summarize the growing body of
knowledge on surgical congenital anomalies in LMICs and
will highlight key research recommendations. An expanded
version of this review will be published as a book chapter
in Disease Control Priorities 3, Volume 3: Essential
Surgery.
Congenital anomalies and the global burden of disease
Congenital anomalies account for a staggering 25.3–38.8
million disability-adjusted life-years (DALYs) worldwide
[20, 21]. DALYs are a well established metric for mea-
suring the burden of disease in terms of both mortality and
morbidity; 1 DALY is 1 healthy year of life lost due to
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disability or premature death. The World Health Organi-
zation’s (WHO) recent global burden of disease (GBD)
study reports that anomalies rank 17th in causes of disease
burden [20]. While impressive, these figures are likely
underestimates due to the limited number of anomalies
included and the difficulties in evaluating incidence, mor-
bidity, and mortality. Only six anomalies were assigned
disability weights in the previous 2004 estimates, and new
disability weights were not estimated for congenital
anomalies in 2012 [21, 22]. Some researchers have tried to
fill the gap with evidence-based estimates of selected dis-
ability-weights [23]. Of the conditions measured in the
GBD study, cardiac defects represent the greatest overall
burden, and, with neural tube defects and cleft lip and
palate, cause 21 million DALYs. Of these, 57 %, or 12
million are estimated to be surgically avertable if outcomes
in HICs could be achieved in LMICs [24]. The GBD study
also reports 361 DALYs per 1,000 population globally
[20]. Strikingly, congenital anomalies may be responsible
for up to 120 DALYs per 1,000 children [25].
In general, current estimates of the surgical burden of
disease are considered a ‘‘best educated guess,’’ given the
‘‘near total lack of pertinent data’’ [26]. Even less is known
about pediatric surgical disease [27]. Extant research paints
a brutal picture of the potential scope and human cost of
pediatric surgical disease.
Incidence, prevalence and treatment of congenital
anomalies in LMICs
A total of 94 % of anomalies occur in LMICs [28].
Higher fertility rates translate to higher birth rates and net
prevalence of anomalies. In addition, the frequency of
pregnancy termination following prenatal diagnosis of a
congenital anomaly is lower in many LMICs than in
HICs. In part, this difference stems from the fact that
elective pregnancy termination following prenatal diag-
nosis may be less available in certain LMICs than in
HICs. Despite a global trend towards liberalization of
termination laws, legal and procedural pushback limit
access to pregnancy termination services in many coun-
tries around the world [29].
Incidence (the frequency with which a disease occurs in
a given population) is also higher in LMICs. This jump has
been attributed to an interaction of multiple contextual
factors, including increased nutritional deficiency, preva-
lence of intrauterine infection, exposure to teratogens, and
self-medication with unsupervised drugs or traditional
remedies [30, 31]. Although decreasing the birth rate may
reduce the net prevalence of congenital anomalies, most
anomalies cannot otherwise be prevented and must be
treated surgically.
Many LMICs lack rigorous congenital anomaly sur-
veillance programs, making accurate calculations of inci-
dence and prevalence difficult [31]. Current calculations,
which range from 4 to 12 cases per 1,000 births, are likely
underestimates due to stigma and exclusion [32–34]. In
addition, the emergent nature of some anomalies can skew
incidence and prevalence data. Children with non-imme-
diately life-threatening anomalies are more likely to sur-
vive until treatment than children with immediately life-
threatening conditions. Hospital-based data therefore
inherently biases the perception of relative incidence and
prevalence such that immediately life-threatening condi-
tions may appear to have a lower incidence than non-
immediately life-threatening anomalies [35]. Population-
based surveys—which directly collect data from non-cen-
tralized sites—represent one approach to addressing this
challenge [25].
The burden of disease associated with congenital
anomalies in LMICs is most often calculated as the mor-
tality rate over a given period of time. These data can be
challenging to analyze in LMICs. In Benin, for example,
only 0.8 % of nearly 1,100 neonatal deaths were investi-
gated with an autopsy. In all examined cases, autopsy
provided additional information on the cause of death [36].
Additionally, non-fatal anomalies can result in extensive,
ongoing morbidity. The burden of disease is grossly
underestimated if measures of this impairment are not
included. Indeed, anomalies resulting in visible deformity
(such as clubfoot and cleft lip) or non-visible anomalies
that cause chronic disability may also cause stigmatization,
which can trigger abandonment or infanticide. An ‘incur-
able’ anomaly may endanger the whole family’s well-
being, as key resources must be allocated to care for the
afflicted child. Families may fracture, with one or both
parents leaving the child with other family members. While
extant calculations of the burden of disease neglect to
measure these harms, these calculations do highlight
marked disparities in survival rates between HICs and
LMICs.
Heightened mortality rates stem from a complex web of
social, economic, and geographic factors. In LMICs, many
births occur at home, either with no attendants or with
traditional birth attendants; pejorative cultural beliefs or
ignorance about possible cures for defects may prevent
families from seeking treatment. If families do seek care,
they must often travel great distances to reach medical
facilities. Hypothermia is common following unsupervised
transport over long distances, with severe repercussions on
outcomes [13, 14, 37]. Misdiagnosis as better known
infectious diseases is common, as are added delays in
diagnosis for non-visible anomalies. These challenges are
exacerbated by the paucity of specialized providers in
LMICs. One pediatric general surgeon may serve millions
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of children [38], and physicians performing pediatric sur-
gery may have little or no pediatric surgery training [39,
40]. While North America has an estimated one pediatric
cardiac surgeon per 3 million people, sub-Saharan Africa
has one per 38 million people [41]; 75 % of the world’s
population is estimated to have no access to cardiac surgery
[42]. Similarly, one-third of the world’s population is
covered by one-twentieth of its neurosurgeons [43]. Delays
in referring patients from local health centers to medical
centers with specialized surgical capacity, and the financial
burden of treatment on families, also limit the accessibility
of treatment for congenital anomalies.
The power of pediatric surgery to reduce the global
burden of disease
Only a small body of literature evaluates the potential of
surgery to reduce the burden of disease associated with
congenital anomalies in terms of DALYs averted or cost
effectiveness. Yet these foundational studies have provided
compelling evidence that pediatric surgery represents a
cost-effective intervention with the potential to avert over
two-thirds of the DALYs associated with birth defects [24,
25, 34, 44–46]. Favorable outcomes have been reported in
HICs for anomalies such as anorectal malformations and
congenital diaphragmatic hernia [47]. In LMICs, the
human capital approach to cleft lip and palate repair has
provided very favorable cost-effectiveness analysis (CEA)
estimates. An extension of this methodology to treatment
for hydrocephalus in Uganda yielded a cost of $US59–126
per DALY averted [48]. Surgical repair of congenital
inguinal hernias in Uganda was estimated to have an
incremental cost-effectiveness ratio (ICER) of $US12/
DALY averted [49]. Another recent report from Cambodia
estimated a CEA of $US99/DALY averted over 3 months
for reconstructive surgery for an array of anomalies [50].
Critically, treating congenital anomalies may translate into
a significantly greater reduction in the economic burden of
disease than that cited above. Since children represent the
future economic engine powering LMICs, the value of
investing in pediatric surgery also encompasses the future
socioeconomic well-being of LMICs. In order to take
advantage of the inherent upside to treating congenital disease
at its inception, research must address the knowledge gaps that
currently impede the development of effective care systems.
Recommended research priorities for pediatric surgery
in LMICs
Based on the available literature, research priorities to
improve pediatric surgery capacity and reduce the burden
of disease attributable to congenital anomalies include the
following:
1. Epidemiology, prevalence, and incidence of disease.
Epidemiology may vary locally, but additional data are
needed [51]. Registries for selected anomalies may
assist in improving surveillance (e.g. by participation
in the International Clearinghouse for Birth Defects
Surveillance and Research). Evaluation of hidden
mortality and morbidity will better approximate the
true burden of disease.
2. Pediatric surgical capacity at all levels of the health
system. Guidelines for minimum human resources and
infrastructure for countries at different levels of
development. While the WHO Situational Analysis
Tool (which evaluates gaps in the availability of
emergency and essential surgical care) only includes
two items pertaining to pediatric surgical care, an
alternative capacity tool has recently been proposed
[52]. This tool could be refined and further evaluated
as it is piloted in different countries. While surgical
outreach programs tackle the backlog of non-emergent
conditions, emergent conditions require development
of the whole health system. More work is needed to
define and develop the mechanisms to strengthen
systems for pediatric surgery.
3. Optimized quantitative metrics of disease burden.
While well accepted, DALYs are difficult to apply
practically. Surgical backlogs can be calculated for
congenital anomalies and can be a useful advocacy
tool to estimate the resources needed to treat common,
non-fatal anomalies. In MICs and HICs, many
prevalent congenital anomalies are treated in the first
year of life; in LICs, they are never treated or are
treated years later, after children have suffered unnec-
essary complications. Improved measurements of the
burden imposed by delayed access to care have not yet
been developed. However, as DALYs are currently the
standard metric, calculating new or better disability-
weights for a broad range of congenital anomalies is
also a viable means by which to improve meaningful
evaluation of the contribution of congenital anomalies
to the global burden of disease.
4. Models for the integration of pediatric surgical
services within existing child health initiatives.
Large-scale child health initiatives (such as the WHO
Integrated Management of Childhood Illness and
Neonatal Resuscitation) have not historically included
surgical care. Similarly, congenital anomalies have not
been addressed through the agenda of the non-
communicable disease movement, despite the fact that
they are at times considered non-communicable
disease (as in the WHO’s recent GBD study). Many
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providers of children’s surgical services share the
concern that the surgical needs of children, if not
explicitly addressed, are often neglected. Additionally,
greater planning is needed between networks of
specialty organizations and providers treating a broad
range of congenital anomalies to collaborate where
possible.
5. Cost-effectiveness data. To the author’s knowledge,
only two attempts to estimate cost effectiveness for
pediatric surgical wards has been made [34, 50]. Low-
cost technical and technological innovations (such as
telemedicine) hold great promise to improve periop-
erative care and training [53]. CEA of training
programs could also aid in advocacy for greater
resources for training.
6. Aligning marketing and advocacy. Greater emphasis has
been directed toward selected visible, treatable anom-
alies (e.g. cleft lip and palate) than to a range of
anomalies for which it has been more difficult to engage
donor programs. Innovative strategies to improve the
multidimensional measurement of the burden of disease
are needed to make these treatable anomalies more
salient for the public health community.
Conclusion
Great disparities exist in the accessibility and quality of
pediatric surgical services between HICs and LMICs. This
gap can only be bridged by jointly building pediatric sur-
gical capacity in LMICs and by conducting rigorous
research to better guide health system development and
allocation of inherently limited resources. Local expertise
and buy-in should be integrated whenever possible in order
to create sustainable systems that increase long-term
capacity and take advantage of the substantial potential
intellectual, creative, and personnel resources of LMICs. It
is an economic and moral imperative that global partners
invest in pediatric surgery as a vital component of reducing
the burden of disease and improving the public health and
economic fortunes of LMICs. Healthy children remain the
only future for society.
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